Ignite Creation Date:
2025-12-25 @ 2:11 AM
Ignite Modification Date:
2025-12-27 @ 9:00 AM
Study NCT ID:
NCT05309460
Status:
RECRUITING
Last Update Posted:
2024-04-12
First Post:
2022-03-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial
Sponsor:
Nebraska Methodist Health System
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NebraskaMethodistHS
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None